Trials Sponsors Conditions Drugs Pricing

Conditions

Endometriosis Pelvic Pain

Keywords

GnRH-aendometriosischronic pelvic painVAS scorediagnostic accuracy

Outcome Measures

Primary Outcomes (1)

Diagnostic accuracy of composite measure (serum CA 125 levels and VAS pain score changes following one dose of GnRH-a)
Diagnostic accuracy (specificity, sensitivity, AUC and cut off levels) of the modifications of serum CA 125 levels and VAS pain score following one dose of LAD (composite measure)
One month after LAD administration

Study Arms (1)

GnRH-analogue

CA125 levels and VAS pain score changes will be assessed after GnRH-a administration in all patients

Drug: GnRH-analogue

Interventions

GnRH-analogueDrug

Also known as: LAD

GnRH-analogue

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 38 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodNon-Probability Sample

Study Population

Patients with chronic pelvic pain

You may qualify if:

chronic pelvic pain

You may not qualify if:

Sponsors & Collaborators

University Magna Graecia
Otherlead

Study Sites (1)

Chair of Obstetrics and Gynecology - University division - UMG

Catanzaro, CZ, 88100, Italy

Related Publications (1)

Venturella R., et al. CA 125 modifications throughout menstrual cycle and following GnRH-analog administration to diagnose endometriosis as cause of chronic pelvic pain.A prospective controlled study. Journal of Endometriosis 2011; 3(3): 151 - 158. DOI: 10.5301/JE.2011.8911
BACKGROUND

MeSH Terms

Conditions

Pelvic PainEndometriosis

Interventions

Gonadotropin-Releasing Hormone

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Study Officials

Fulvio Zullo
Magna Graecia University of Catanzaro
PRINCIPAL INVESTIGATOR

Enrollment

118 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Full Professor Obstetric Gynecology

Study Record Dates

First Submitted

March 15, 2014

First Posted

March 19, 2014

Study Start

January 2011

Date type not reported

This date has not been verified as actual or estimated.

CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

GnRH-analogue

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

GnRH-analogue

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations